Clik here to view.
Sigma-concepts.com a Website for excellent reading with figures & diagrams
READ http://6sigma-concepts.com/ Dr. Amrendra Kumar Roy QbD Head, Jubilant Generics, NOIDA A Six-sigma and QbD professional akroy1975@gmail.com Twitter 6sigmaconcepts sigma-concepts.com WEBSITE...
View ArticleClik here to view.
SUGAMMADEX
SUGAMMADEX CAS number 343306-71-8 Weight Average: 2002.12 Monoisotopic: 2000.408874758 Chemical Formula C72H112O48S8 WATCH OUT POST WILL BE UPDATED……… SUGAMMADEX 343306-71-8 cas free Sugammadex...
View ArticleClik here to view.
FDA approves Intrarosa for postmenopausal women experiencing pain during sex
FDA approves Intrarosa for postmenopausal women experiencing pain during sex The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain...
View ArticleClik here to view.
Opportunities for Reducing Sampling and Testing of Starting Materials
DRUG REGULATORY AFFAIRS INTERNATIONAL Chapter 5 of the EC GMP Guide for the area of production was updated last year. This chapter contains concrete information about the conditions when testing and...
View ArticleClik here to view.
New EDQM’s Public Document informs about the Details required in a New CEP...
DRUG REGULATORY AFFAIRS INTERNATIONAL A Policy Document recently published by the EDQM describes regulations for referencing already existing CEPs in an application for a new CEP. Read more about how...
View ArticleClik here to view.
Now online – Stimuli article on the proposed USP General Chapter “The...
DRUG REGULATORY AFFAIRS INTERNATIONAL Now online – Stimuli article on the proposed USP General Chapter “The Analytical Procedure Lifecycle <1220>” A Stimuli Article to the Revision Process...
View ArticleClik here to view.
LUPIN LIMITED, WO 2016181313, NEW PATENT, SOFOSBUVIR
WO2016181313, A PROCESS FOR THE PREPARATION OF SOFOSBUVIR INTERMEDIATES & ITS POLYMORPH LUPIN LIMITED [IN/IN]; Kalpataru Inspire 3rd Floor, Off Western Express Highway Santacruz (East) Mumbai 400...
View ArticleClik here to view.
Doxercalciferol, доксэркальциферол , دوكساركالسيفيرول , 度骨化醇
Doxercalciferol Molecular FormulaC28H44O2 Average mass412.648 доксэркальциферол [Russian] دوكساركالسيفيرول [Arabic] 度骨化醇 [Chinese] 1,3-Cyclohexanediol,...
View ArticleClik here to view.
SUVEN LIFE SCIENCES LTD, WO 2016178064, POLYMORPH OF NINTEDANIB...
NINTEDANIB ETHANESULPHONATE NEW PATENT WO2016178064, CLICK FOR PATENT POLYMORPH OF NINTEDANIB ETHANESULPHONATE, PROCESSES AND INTERMEDIATES THEREOF SUVEN LIFE SCIENCES LIMITED [IN/IN]; 5th floor,...
View ArticleClik here to view.
Sacubitril, WO 2016180275, New patent, SUZHOU PENGXU PHARMATECH CO., LTD
Sacubitril, WO 2016180275, New patent, SUZHOU PENGXU PHARMATECH CO., LTD AHU-377 INTERMEDIATES AND METHOD FOR PREPARING AHU-377 AND AHU-377 INTERMEDIATES PATENT WO2016180275, new patent, SUZHOU PENGXU...
View ArticleClik here to view.
IPRAGLIFLOZIN, NEW PATENT, WO2016173551, China State Institute of...
WO 2016173551 China State Institute of Pharmaceutical Industry; Shanghai Institute of Pharmaceutical Industry...
View ArticleClik here to view.
WO 2016181414, IVACAFTOR, NEW PATENT, COUNCIL OF SCIENTIFIC & INDUSTRIAL...
CSIR, Dr. D. Srinivasa Reddy WO2016181414, PROCESS FOR THE SYNTHESIS OF IVACAFTOR AND RELATED COMPOUNDS...
View ArticleClik here to view.
Generics: FDA´s New Guidance on Prior Approval Supplements
DRUG REGULATORY AFFAIRS INTERNATIONAL Generics: The US Food and Drug Administration (FDA) recently published a new Guidance regarding Prior Approval Supplements (PAS). Read more about FDA´s Guidance...
View ArticleClik here to view.
ZINPLAVA (BEZLOTOXUMAB), Approved FDA
BEZLOTOXUMAB Biologic License Application (BLA): 761046 Company: MERCK SHARP DOHME Drug Name(s): • ZINPLAVA (BEZLOTOXUMAB) http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf...
View ArticleClik here to view.
Clik here to view.
Ranolazine Intermediate, An Efficient Synthesis of...
An efficient process for the preparation of 1-(2-methoxyphenoxy)-2,3-epoxypropane, a key intermediate for the synthesis of ranolazine is described. http://pubs.acs.org/doi/suppl/10.1021/op300056k...
View ArticleClik here to view.
Designing Polymers for Amorphous Solid Dispersions — AAPS Blog
By: Laura I. Mosquera-Giraldo and Lynne S. Taylor Imagine spending billions of dollars in the discovery of a new drug, and then realizing that it is impractical to administer it orally because it...
View ArticleClik here to view.
Lumefantrine
lumefantrine 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol (±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol...
View ArticleClik here to view.
CEP 33779
CEP-33779, CEP33779 CAS 1257704-57-6 Chemical Formula: C24H26N6O2S Molecular Weight: 462.57 Elemental Analysis: C, 62.32; H, 5.67; N, 18.17; O, 6.92; S, 6.93...
View ArticleClik here to view.
PIMODIVIR, VX 787
PIMODIVIR VX-787, JNJ-63623872, JNJ-872, VRT-0928787, VX-787, VX 787, VX787, JNJ-872, JNJ 872, JNJ872, VRT-0928787, VRT 0928787, VRT0928787, pimodivir...
View Article